Trillium Therapeutics Inc.(SCTPF)- OTCQX
SCTPF is defunct.
Company Description
Trillium Therapeutics Inc. is an immuno-oncology company developing innovative therapies for the treatment of cancer. The Company has two premier preclinical programs, SIRPaFc and a CD200 monoclonal antibody (mAb), which target two key immunoregulatory pathways that tumor cells exploit to evade... More
Sector: Services
Industry: Business Services
Country: Canada